Memo Therapeutics Ag To Receive Chf 10.5 Million From Swiss Federal Funding Programme To Clinically Develop Sars-Cov-2 Antibody Against Covid-19
Round Type
Funding Round
SchlierenBiotechnologyHealth CareScience And EngineeringDescription
Memo Therapeutics AG, an innovator in the field of antibody discovery and development, announced today the receipt of CHF10.5 million from the Swiss Federal Funding Programme for COVID-19 Medicines to clinically develop COVAB 36, a potent, fully-human monoclonal antibody for the treatment of SARS-CoV-2 infections. COVAB 36 can be administered via inhalation, which could enhance patient acceptance. The project also includes the ability to rapidly develop a combination antibody partner for COVAB 36 targeted against emerging variants through an ultra-fast update process based on Memo Therapeutic AG’s leading antibody discovery platform.
Quick answer
Memo Therapeutics AG raised an undisclosed amount in a Funding Round round, dated December 13, 2021. Memo Therapeutics AG is based in Schlieren, Zurich, Switzerland.
- How much did Memo Therapeutics AG raise?
- Memo Therapeutics AG raised an undisclosed amount in a Funding Round round on December 13, 2021.
- What does Memo Therapeutics AG do?
- Memo Therapeutics AG is an innovator in the field of antibody discovery and immune repertoire analysis.
- Where is Memo Therapeutics AG based and how big is it?
- Memo Therapeutics AG is based in Schlieren, Zurich, Switzerland.
- Who are the decision-makers at Memo Therapeutics AG?
- Fundz holds 1 contact at Memo Therapeutics AG. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Science And Engineering and Biotechnology around the same time
Companies in the same sectors as Memo Therapeutics AG that raised within 45 days of this round, from Fundz verified event records.
- Septerna raised $100M (Series A) on January 27, 2022.
- Advanced NanoTherapies raised $9.2M on January 26, 2022.
- Kyverna Therapeutics raised $85M (Series B) on January 26, 2022.
- Enliven Therapeutics raised an undisclosed amount (Funding Round) on January 19, 2022.
- Feldan Therapeutics raised an undisclosed amount (Funding Round) on January 18, 2022.
- PostEra Inc. raised $26M on January 14, 2022.
Who to call at Memo Therapeutics AG, and when
A new round usually means Memo Therapeutics AG is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Memo Therapeutics AG raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Memo Therapeutics AG, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Memo Therapeutics AG. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Memo Therapeutics AG raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Memo Therapeutics AG raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.